The development of a fully-integrated immune response model (FIRM) simulator of the immune response through integration of multiple subset models

BMC Systems Biology

Volumn 7, Issue , 2013, Pages

  Palsson, Sirus ^a   Hickling, Timothy P ^b   Bradshaw Pierce, Erica L ^c,d   Zager, Michael ^c   Jooss, Karin ^c   O'Brien, Peter J ^c   Spilker, Mary E ^c   Palsson, Bernhard O ^a   Vicini, Paolo ^c  

^a GT Life Sciences   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^c PFIZER INC   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

Biological networks; Immune response; Mathematical modeling; Ordinary differential equation systems; Systems biology

Indexed keywords

BACTERIA (MICROORGANISMS); MAMMALIA;

ARTICLE; B LYMPHOCYTE; BIOLOGICAL MODEL; BLOODBORNE BACTERIUM; IMMUNITY; IMMUNOLOGY; KINETICS; METHODOLOGY; NEOPLASM; SYSTEMS BIOLOGY; T LYMPHOCYTE; TUBERCULOSIS; PROCEDURES;

B-LYMPHOCYTES; BLOOD-BORNE PATHOGENS; IMMUNITY; KINETICS; MODELS, IMMUNOLOGICAL; NEOPLASMS; SYSTEMS BIOLOGY; T-LYMPHOCYTES; TUBERCULOSIS;

EID: 84884623483     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-7-95     Document Type: Article

References (39)

1. Anderson ARA, Quaranta V. Integrative mathematical oncology. Nat Rev Cancer 2008, 8(3):227-234. 10.1038/nrc2329, 18273038.
2. Bauer AL, Beauchemin CAA, Perelson AS. Agent-based modeling of host-pathogen systems: The successes and challenges. Inform Sci 2009, 179(10):1379-1389.
3. Mestas J, Hughes CCW. Of Mice and Not Men: Differences between Mouse and Human Immunology. J Immunol 2004, 172(5):2731-2738.
4. Perelson AS, Weisbuch G. Immunology for physicists. Rev Mod Phys 1997, 69(4):1219-1268.
5. De Boer RJ, et al. Macrophage T lymphocyte interactions in the anti-tumor immune response: a mathematical model. J Immunol 1985, 134(4):2748-2758.
6. De Pillis LG, Radunskaya AE, Wiseman CL. A validated mathematical model of cell-mediated immune response to tumor growth. Cancer Res 2005, 65(17):7950-7958.
7. Kirschner D, Panetta JC. Modeling immunotherapy of the tumor-immune interaction. J Math Biol 1998, 37(3):235-252. 10.1007/s002850050127, 9785481.
8. Bell GI. Mathematical model of clonal selection and antibody production. J Theor Biol 1970, 29(2):191-232. 10.1016/0022-5193(70)90019-6, 5500468.
9. Kolev M. Mathematical modeling of the competition between acquired immunity and cancer. Int J Appl Math Comput Sci 2003, 13(3):289-296.
10. Marino S, Kirschner DE. The human immune response to Mycobacterium tuberculosis in lung and lymph node. J Theor Biol 2004, 227(4):463-486. 10.1016/j.jtbi.2003.11.023, 15038983.
11. Burke MA, et al. Modeling the Proliferative Response of T Cells to IL-2 and IL-4. Cell Immunol 1997, 178(1):42-52. 10.1006/cimm.1997.1125, 9184697.
12. Cheng Y, et al. A discrete computer model of the immune system reveals competitive interactions between the humoral and cellular branch and between cross-reacting memory and naïve responses. Vaccine 2009, 27(6):833-845. 10.1016/j.vaccine.2008.11.109, 19101600.
13. Celada F, Seiden PE. A computer model of cellular interactions in the immune system. Immunol Today 1992, 13(2):56-62. 10.1016/0167-5699(92)90135-T, 1575893.
14. Castiglione F, et al. A Network of Cellular Automata for the Simulation of the Immune System. INTERNATIONAL JOURNAL OF MODERN PHYSICS C 1999, 10:677-686.
15. Puzone R, et al. IMMSIM, a flexible model for in machina experiments on immune system responses. Futur Gener Comput Syst 2002, 18(7):961-972.
16. Kohler B, et al. A systematic approach to vaccine complexity using an automaton model of the cellular and humoral immune system: I. Viral characteristics and polarized responses. Vaccine 2000, 19(7-8):862-876.
17. Cappuccio A, Castiglione F, Piccoli B. Determination of the optimal therapeutic protocols in cancer immunotherapy. Math Biosci 2007, 209(1):1-13. 10.1016/j.mbs.2007.02.009, 17416392.
18. Castiglione F, Piccoli B. Cancer immunotherapy, mathematical modeling and optimal control. J Theor Biol 2007, 247(4):723-732. 10.1016/j.jtbi.2007.04.003, 17543345.
19. Kirschner D, Marino S. Mycobacterium tuberculosis as viewed through a computer. Trends Microbiol 2005, 13(5):206-211. 10.1016/j.tim.2005.03.005, 15866037.
20. Kirschner DE, et al. Toward a multiscale model of antigen presentation in immunity. Immunol Rev 2007, 216(1):93.
21. Kim PS, Lee PP, Levy D. Modeling regulation mechanisms in the immune system. J Theor Biol 2007, 246(1):33-69. 10.1016/j.jtbi.2006.12.012, 17270220.
22. Agoram BM, Martin SW, van der Graaf PH. The role of mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modelling in translational research of biologics. Drug Discov Today 2007, 12(23-24):1018-1024.
23. Mager DE, Jusko WJ. Development of Translational Pharmacokinetic-Pharmacodynamic Models. Clin Pharmacol Ther 2008, 83(6):909-912. 10.1038/clpt.2008.52, 2671003, 18388873.
24. Melder RJ, et al. Systemic distribution and tumor localization of adoptively transferred lymphocytes in mice: comparison with physiologically based pharmacokinetic model. Neoplasia 2002, 4(1):3-8. 10.1038/sj.neo.7900209, 1503314, 11922388.
25. Garg A, Balthasar J. Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice. J Pharmacokinet Pharmacodyn 2007, 34(5):687-709. 10.1007/s10928-007-9065-1, 17636457.
26. Mager DE, Wyska E, Jusko WJ. Diversity of Mechanism-Based Pharmacodynamic Models. Drug Metab Dispos 2003, 31(5):510-518. 10.1124/dmd.31.5.510, 12695336.
27. Vicini P. Multiscale Modeling in Drug Discovery and Development: Future Opportunities and Present Challenges. Clin Pharmacol Ther 2010, 88(1):126-129. 10.1038/clpt.2010.87, 20520608.
28. Sorger PK, et al. Quantitative and Systems Pharmacology in the Post-genomic Era: New Approaches to Discovering Drugs and Understanding Therapeutic Mechanisms 2011, An NIH White Paper by the QSP Workshop Group, http://www.nigms.nih.gov/nr/rdonlyres/8ecb1f7c-be3b-431f-89e6-a43411811ab1/0/systemspharmawpsorger2011.pdf.
29. Webb K, White T. UML as a cell and biochemistry modeling language. Biosystems 2005, 80(3):283-302. 10.1016/j.biosystems.2004.12.003, 15888343.
30. Ayyadurai V, Dewey C. CytoSolve: A Scalable Computational Method for Dynamic Integration of Multiple Molecular Pathway Models. Cell Mol Bioeng 2011, 4(1):28-45. 10.1007/s12195-010-0143-x, 3032229, 21423324.
31. Palsson B. Systems biology: properties of reconstructed networks 2006, Cambridge: Cambridge Univ Pr.
32. Jamshidi N, Palsson B. Mass Action Stoichiometric Simulation Models: Incorporating Kinetics and Regulation into Stoichiometric Models. Biophys J 2010, 98(2):175-185. 10.1016/j.bpj.2009.09.064, 2808481, 20338839.
33. Weinberg RA. The biology of cancer 2007, New York: Garland Science.
34. Colombo MP, Piconese S. Regulatory-T-cell inhibition versus depletion: the right choice in cancer immunotherapy. Nat Rev Cancer 2007, 7(11):880-887. 10.1038/nrc2250, 17957190.
35. Park J, et al. Natural immunosurveillance against spontaneous, autochthonous breast cancers revealed and enhanced by blockade of IL-13-mediated negative regulation. Cancer Immunol Immunother 2008, 57(6):907-912. 10.1007/s00262-007-0414-0, 18004566.
36. Edwards JS, Palsson BO. Systems Properties of the Haemophilus influenzaeRd Metabolic Genotype. J Biol Chem 1999, 274(25):17410-17416. 10.1074/jbc.274.25.17410, 10364169.
37. Feist AM, Palsson BO. The growing scope of applications of genome-scale metabolic reconstructions using Escherichia coli. Nat Biotech 2008, 26(6):659-667.
38. Duarte NC, et al. Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci 2007, 104(6):1777-1782. 10.1073/pnas.0610772104, 1794290, 17267599.
39. Gianchandani EP, et al. Functional States of the Genome-Scale Escherichia Coli Transcriptional Regulatory System. PLoS Comput Biol 2009, 5(6):e1000403. 10.1371/journal.pcbi.1000403, 2685017, 19503608.